- Defining functional neurological disorder
- Clinical presentation and diagnostic criteria
- Differential diagnoses and comorbidities
- Approaches to treatment and management
- Improving patient outcomes and professional awareness
Functional neurological disorder (FND) refers to a condition characterised by neurological symptoms that are not explained by traditional structural disease, but rather by changes in the way the nervous system functions. These symptoms can significantly impact daily life and may resemble those seen in conditions such as epilepsy, movement disorders, or sensory deficits. However, what differentiates FND is that the symptoms arise without an identifiable lesion or structural abnormality detectable through conventional imaging or laboratory tests.
Historically labelled under terms like “conversion disorder” or “psychogenic disorder”, FND has undergone a reevaluation in contemporary medical understanding. The modern conceptualisation recognises FND as a diagnosis with a clear neurobiological basis, often involving a complex interaction between psychological, physiological, and behavioural elements. This shift in perspective has been crucial in reducing stigma and improving legitimacy for patients affected by FND, facilitating better integration into clinical practice.
Clinicians now identify FND through positive signs on examination rather than by exclusion alone. Examples include Hoover’s sign for functional limb weakness and entrainment tests for tremors. These clinical findings highlight inconsistent or incongruent patterns of neurological functioning that do not conform to recognised anatomical pathways. As a result, the diagnosis becomes more robust and defensible within medical frameworks, supporting earlier recognition and improved patient engagement.
One of the defining features of functional neurological disorder is the presence of genuine symptoms that cannot be faked or voluntarily produced. Patients with FND are not malingering; their distress and disability are real, though the symptoms stem from altered nervous system function rather than organic damage. Understanding this is essential in clinical practice, particularly to foster trust between patient and clinician and avoid mislabelling or dismissing the presentation.
Advances in neuroimaging and cognitive neuroscience have begun to reveal mechanisms that may underlie FND, including alterations in brain networks involved in motor planning, attention, and emotion regulation. These findings help explain how dysfunction can occur without detectable damage and support the legitimacy of FND as a medical condition deserving of evidence-based care and multidisciplinary attention.
Clinical presentation and diagnostic criteria
The clinical presentation of functional neurological disorder is notably diverse and can encompass a range of motor, sensory, and cognitive symptoms. Patients may present with limb weakness, tremors, episodes resembling epileptic seizures (known as dissociative seizures), speech disturbances, gait abnormalities, or sensory loss. These symptoms often fluctuate in intensity and can be variable over short periods, further distinguishing them from structural neurological diseases. Importantly, they can mimic the manifestations of conditions such as stroke, multiple sclerosis, and epilepsy, which may initially lead to extensive investigations before the correct diagnosis is made.
Diagnosis in clinical practice is not reliant on the absence of other disease processes but rather on the presence of positive clinical signs. These signs are elicited through systematic examination and do not conform to recognised anatomical or physiological patterns. For instance, Hoover’s sign demonstrates inconsistent effort in leg weakness, while functional tremors may change with distraction or co-movement tasks. These inconsistencies are not indicative of deliberate deception but point towards altered nervous system functioning that is characteristic of FND. Recognising such signs enables clinicians to give patients a timely and confident diagnosis, reducing uncertainty and unnecessary investigations.
Another hallmark of functional neurological disorder is internal inconsistency. For example, a patient may be unable to initiate arm movement when asked but may demonstrate full function during a reflexive action such as catching a falling object. This variability strongly supports the diagnosis when seen during clinical assessment. These observations are a crucial shift from prior frameworks, which predominantly focused on excluding organic pathology, and signify a more nuanced and supportive approach to patients.
It is also common for FND symptoms to be precipitated by physical or emotional stressors, though this is not universal and should not be required for diagnosis. In some cases, trauma, such as injury or psychological distress, may precede symptom onset. However, many individuals do not exhibit an identifiable trigger, reinforcing the importance of a diagnosis based on clinical signs rather than inferred psychological causation. This understanding is essential in avoiding assumptions that symptoms are ‘all in the mind’, which can contribute to stigma and reduced quality of care.
Psychiatric comorbidities, such as anxiety and depression, may be present but are not diagnostic criteria for FND. Their presence should be explored with sensitivity, and appropriate support offered where needed. Likewise, the presence of FND should not preclude the possibility of concurrent neurological pathology, emphasising the need for comprehensive and careful evaluation. Ultimately, the goal in clinical practice is to arrive at a diagnosis that is both accurate and communicated in a way that validates the patient’s experiences while guiding effective management.
Differential diagnoses and comorbidities
Distinguishing functional neurological disorder from other conditions in clinical practice requires a nuanced understanding of both its presentations and how they might overlap with other neurological or psychiatric diagnoses. Numerous disorders can mimic the symptoms of FND, making differential diagnosis a key step in providing accurate and compassionate care. Conditions such as multiple sclerosis, epilepsy, stroke, Parkinson’s disease, and myasthenia gravis can all present with motor and sensory disturbances similar to those seen in FND. Careful neurological examination, supported by appropriate investigations, remains essential to rule out these structural or metabolic causes without delaying the recognition of functional symptoms when present.
One of the most frequently encountered challenges is differentiating FND-related seizures—referred to as dissociative or non-epileptic attacks—from epileptic seizures. Both may present with convulsions, unresponsiveness or other paroxysmal occurrences. However, dissociative seizures typically show distinctive patterns, such as prolonged duration, asynchronous movements, and absence of postictal confusion. Video-EEG monitoring can be invaluable in confirming diagnosis, especially in cases where uncertainty persists after initial assessment. Misdiagnosis in either direction—mistaking epileptic seizures for functional or vice versa—can lead to inappropriate treatment and significant patient distress.
It is also increasingly recognised that FND frequently coexists with other medical conditions, both neurological and psychiatric. Patients may have co-occurring epilepsy, migraine, fibromyalgia, or chronic pain disorders. In these situations, one condition may overshadow the other, complicating clinical interpretation. Additionally, comorbid mental health conditions such as anxiety disorders, depression, and post-traumatic stress disorder are prevalent among individuals with FND, though not universally present. These associations do not imply causality but highlight overlapping vulnerabilities and underline the necessity for a holistic diagnostic approach.
The risk of diagnostic overshadowing—where a diagnosis of FND leads to dismissal of new or concurrent symptoms—is a significant concern in clinical practice. Patients with an existing FND diagnosis are sometimes inadvertently excluded from investigation for new complaints that may be indicative of an emerging organic illness. Therefore, an inclusive and dynamic process of reassessment is crucial. Diagnosis of FND should never be seen as the final interpretative frame but rather as one component of an evolving clinical picture that must be reevaluated as new information arises.
Autism spectrum disorders and attention-deficit/hyperactivity disorder, although less commonly discussed in the context of FND, are also found as comorbidities in some patients and may influence symptom expression, awareness, and response to treatment. Recognising these conditions can help tailor communication strategies and therapeutic interventions more effectively, fostering better patient engagement. Equally, personality traits or disorders may intersect with functional symptoms in ways that affect coping mechanisms and patterns of health care use. Clinicians are encouraged to consider these elements within a biopsychosocial framework rather than as determinants of the disorder.
Ultimately, a robust diagnosis of functional neurological disorder is achieved not by exclusion but by the identification of positive clinical features and the thoughtful exclusion of alternative explanations. Awareness of differential diagnoses and comorbidities is essential not only to avoid misdiagnosis but also to provide comprehensive care that addresses the full range of a patient’s health needs. A multidisciplinary approach, incorporating neurology, psychiatry, psychology, and physiotherapy, increases the likelihood of accurate diagnosis and effective management in the complex landscape of FND presentations.
Approaches to treatment and management
Effective treatment and management of functional neurological disorder centre on a collaborative, multidisciplinary approach tailored to the patient’s specific symptom profile, psychological needs, and functional goals. Central to this approach is clear communication of the diagnosis, delivered with clarity, compassion, and confidence. Research shows that patients are more likely to engage with treatment and experience symptom improvement when they understand their condition and feel reassured that their symptoms are real, recognised, and manageable within the framework of modern clinical practice.
Explaining the diagnosis of FND to patients involves highlighting that their symptoms are genuine and arise from changes in brain function rather than from structural damage. Useful analogies, such as comparing FND to a computer displaying an error despite the absence of hardware damage, can help normalise the condition and reduce stigma. The diagnostic conversation should also address the reversibility of symptoms in many cases, setting realistic expectations while maintaining hope.
Physiotherapy plays a central role in the management of functional motor symptoms. Specialised physiotherapy for FND focuses on retraining normal movement patterns by redirecting attention and building automaticity—skills that may be disrupted in FND. Therapists work with patients to promote body awareness and functional restoration, incorporating task-specific exercises that minimise symptom reinforcement. This approach differs markedly from conventional neurorehabilitation and must be delivered by clinicians familiar with the functional nature of the symptoms.
For individuals with dissociative (non-epileptic) seizures, psychological therapy—particularly cognitive behavioural therapy (CBT)—has demonstrated clinical benefit. CBT aims to reduce distressing arousal states, explore illness beliefs, and address maladaptive thought patterns and behaviours that may contribute to symptom perpetuation. Other psychotherapeutic interventions, such as psychodynamic therapy or acceptance and commitment therapy, may be appropriate depending on individual preference and therapeutic goals. Importantly, therapeutic efforts should be paced in a patient-centred way, recognising that readiness for psychological exploration may vary.
Occupational therapy can assist in restoring daily function, supporting patients to re-engage with meaningful activities and manage fatigue or cognitive difficulties. Speech and language therapy may also be appropriate for patients experiencing functional speech or swallowing disturbances. Education about symptom management, pacing strategies, and graded return to activity is commonly integrated across all disciplines, ensuring a holistic and unified treatment plan.
In clinical practice, early multidisciplinary involvement and prompt communication of the diagnosis are associated with better outcomes. Delays in explaining the diagnosis or inappropriate use of language (e.g., implying symptoms are “in the mind” or psychogenic) can reinforce patient uncertainty and reduce engagement. Facilitating collaboration between neurology and mental health professionals is crucial, particularly in settings where specialist FND services may be limited. Embedding FND management within general neurology teams can help fill treatment gaps and prevent unwarranted service exclusion.
Pharmacological interventions are not typically the primary mode of treatment for functional symptoms but may be considered when comorbidities such as anxiety, depression, or sleep disturbance are present. Any use of medication should be judicious and reviewed regularly to minimise the risk of polypharmacy and side effects. Where pain or fatigue are prominent features, careful assessment is needed to determine whether these symptoms relate to coexisting conditions or are part of the functional presentation, guiding appropriate management strategies.
Effective coordination of care ensures that the patient does not feel “abandoned” after diagnosis and supports ongoing functional improvement. Regular review, goal-setting, and an emphasis on collaborative rehabilitation foster a sense of agency and progress. Where possible, involvement of families or carers in the treatment process can enhance understanding and provide an important support network for the patient.
Although treatment plans vary depending on individual needs, the core principles of FND management remain consistent: validating the patient’s experience, delivering the diagnosis skilfully, and using tailored, evidence-based therapies within a multidisciplinary framework. As awareness of functional neurological disorder continues to expand within healthcare, so too does the potential for improved outcomes through more integrated and responsive models of care.
Improving patient outcomes and professional awareness
To improve outcomes for individuals with functional neurological disorder, significant focus must be placed on enhancing the integration of services, clinician education, and communication strategies within clinical practice. Timely and accurate diagnosis, delivered with clarity and empathy, is a foundational step in establishing therapeutic alliance and guiding effective care. However, efforts to improve patient outcomes must go beyond the initial diagnostic encounter to address systemic factors that shape the quality and accessibility of ongoing treatment.
Professional awareness of FND among healthcare providers remains variable, contributing to delays in diagnosis, inappropriate investigations, and inconsistent management strategies. Increasing educational exposure at both undergraduate and postgraduate levels is essential to equip clinicians with the skills necessary to recognise positive diagnostic signs and engage confidently with patients. Simulation-based training, case studies, and interprofessional workshops have been shown to foster greater knowledge of FND and reduce stigma, ultimately enhancing clinicians’ ability to deliver supportive and informed care.
A multidisciplinary approach continues to be the hallmark of effective FND management. However, patients frequently encounter fragmented services, where neurological, psychological, and rehabilitative inputs are not well co-ordinated. Establishing clear clinical pathways and dedicated FND services can enhance access to appropriate therapies, reduce duplication of effort, and prevent patients from falling through service gaps. Where specialist services are unavailable, embedding functional disorder expertise within general neurology and mental health teams can offer a pragmatic solution that avoids unnecessary referrals or disengagement.
Patient engagement is significantly influenced by how the diagnosis is communicated. Research suggests that individuals with FND are more likely to participate in rehabilitation and report improved outcomes when the diagnosis is presented as understandable, legitimate, and hopeful. Using neutral, non-judgemental language and tailored explanations helps to validate patients’ experiences and challenge common misconceptions. Encouragingly, when clinicians express confidence in the diagnosis and explain its mechanism, patients often feel relieved and motivated to take an active role in their recovery.
The development and dissemination of patient education materials also support improved understanding and self-management. Leaflets, videos, and online resources created in collaboration with individuals who have lived experience of FND can empower patients and reduce reliance on repeated consultations for clarification. These materials should aim to demystify the condition, address common concerns, and offer practical advice on coping, accessing support, and engaging with treatment options.
Another area critical to improving outcomes is reducing stigma—both within healthcare systems and in wider society. Functional neurological disorder is often misunderstood or perceived as being associated solely with psychological distress, which overlooks its complex neurobiological and biopsychosocial basis. Promoting accurate, person-centred narratives about FND in medical literature, media, and patient advocacy can help shift attitudes and ensure that individuals with the condition are treated with the same compassion and seriousness afforded to those with structural diseases.
Long-term follow-up and collaborative goal-setting are essential to sustaining gains achieved through treatment. Regular reviews offer opportunities to monitor progress, adapt therapies, and address emerging needs. Some patients may need ongoing support to manage symptoms, prevent relapse, or navigate challenges such as return to work or social reintegration. Building strong therapeutic relationships rooted in trust and open communication remains central to facilitating recovery and fostering resilience.
Collecting patient-reported outcome measures and real-world data on treatment effectiveness also contributes to service development and research. Clinicians and services should be supported to engage in quality improvement initiatives, such as audit and patient feedback, to identify gaps and refine care pathways. Fostering professional networks and sharing best practices across institutions can enhance the standard of care delivered to those with FND and promote innovation in treatment delivery.
Ultimately, improving patient outcomes in functional neurological disorder relies on a collective effort to raise professional awareness, cultivate clinical confidence, and embed person-centred values in everyday practice. By shaping clinical environments that recognise and respond to the distinct challenges of FND, healthcare systems can offer more compassionate, effective, and equitable care to this often marginalised population.
